Systemic sclerosis in men;Sclérodermie systémique chez l'homme

Revue de Medecine Interne

Volumn 29, Issue 3, 2008, Pages 181-186

  Gaultier, J B ^a   Hot, A ^b   Cathebras P ^c   Grange, C ^a   Ninet, J ^b   Rousset, H ^a  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c HÔPITAL NORD   (France)

Author keywords

Male gender; Systemic sclerosis

Indexed keywords

ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; ENVIRONMENTAL FACTOR; FEMALE; FOLLOW UP; FRANCE; HUMAN; INTERSTITIAL LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; SEX DIFFERENCE; SKIN DISEASE; SKIN ULCER; SYSTEMIC SCLEROSIS; THORAX RADIOGRAPHY; COHORT ANALYSIS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDY; TIME;

COHORT STUDIES; CONFIDENCE INTERVALS; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SCLERODERMA, SYSTEMIC; SEX FACTORS; TIME FACTORS;

EID: 42149090472     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2007.07.010     Document Type: Article

References (29)

1. Scussel-Lonzetti L., Joyal F., Raynauld J.P., Roussin A., Rich E., Goulet J.R., et al. Predicting mortality in systemic sclerosis. Analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine 81 (2002) 154-167
2. Ferri C., Valentini G., Cozzi F., Sebastini M., Michelassi C., La Montagna G., et al. Systemic sclerosis. Demographic, clinical and serological features and survival in 1012 Italian patients. Medicine 81 (2002) 139-153
3. Barnett A.J., Miller M.H., and Littlejohn G.O. A survival study of patients with scleroderma diagnosed over 30 years (1953-1983): the value of a simple cutaneous classification in the early stages of the disease. J Rheumatol 15 (1988) 276-283
4. Leroy E.C., Black C., Fleischmajer R., et al. Scleroderma (Systemic sclerosis) : classification, subsets and pathogenesis. J Rheumatol 15 (1988) 202-205
5. Medsger T.A., and Masi A.T. Epidemiology of systemic sclerosis (Scleroderma). Ann Intern Med 74 (1971) 714-721
6. Steen V., Oddis C.V., Conte C.G., Janoski J., Casterline G.Z., and Medsger T.A. Incidence of systemic sclerosis in Allegheny county, Pennsylvania. Arthritis Rheum 40 (1997) 441-445
7. Mayes M.D., Lacey J.V., Beebe-Dimmer J., et al. Prevalence, incidence and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 43 (2003) 2246-2255
8. Nietert P.J., and Silver R.M. Systemic sclerosis: environmental and occupational risk factors. Curr Opin Rheumatol 12 (2000) 520-526
9. Hallé O., Schaeverbeke T., Bannwarth B., and Dehais J. Les facteurs d'environnement et les éléments iatrogènes dans la sclérodermie systémique et les syndromes apparentés. Revue de la literature. Rev Med Interne 18 (1997) 219-229
10. Maitre A., Hours M., Bonneterre V., Arnaud J., Arslan M.T., Carpentier P., et al. Systemic sclerosis and occupational risk factors: role of solvents and cleaning products. J Rheumatol (2004) 2395-2401
11. Magnant J., and Diot E. Systemic sclerosis: epidemiology and environmental factors. Presse Med 35 (2006) 1894-1901
12. Medsger T.A., Masi A.T., Rodnan G.P., Benedk T.G., and Robinson H. Survival with systemic sclerosis (Scleroderma). A life-table analysis of clinical and demographic factors in 309 patients. Ann Intern Med 75 (1971) 369-376
13. Hesselstrand R., Scheja A., and Akesson A. Mortality and causes of death in a Swedish series of systemic sclerosis patients. Ann Rheum Dis 57 (1998) 682-686
14. Jacobsen S., Halberg P., and Ullman S. Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma). Br J Rheumatol 37 (1988) 750-755
15. Altman R.D., Medsger T.A., Bloch D.A., and Michel B.A. Predictors of survival in systemic sclerosis. Arthritis Rheum 34 (1991) 403-413
16. Simeon C.P., Armadans L., Fonollosa V., et al. Survival prognostic factor and markers of morbidity in Spanish patients with systemic sclerosis. Ann Rheum Dis 56 (1997) 723-728
17. Leroy E.C., and Medsger T.A. Criteria for the classification of early systemic sclerosis. J Rheumatol 28 (2001) 1573-1576
18. Subcommittee for scleroderma criteria of the American Rheumatism association diagnostic and therapeutic criteria committee Preliminary criteria for the classification of systemic sclerosis. Arthritis Rheum 1980;23:581-90.
19. Mukerjee D., St George D., Knight C., et al. Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis. Rheumatology 43 (2004) 461-466
20. British cardiac society guidelines and medical practice committee, and approved by the British thoracic society and the British society of rheumatology. Recommendations on the management of pulmonary hypertension in clinical practice. Heart 2001;86:i1-i13.
21. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991;144:1202-18.
22. Khanna D., Clements P.J., Furst D.E., et al. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis. Results from the scleroderma lung study. Arthritis Rheum 52 (2005) 592-600
23. Ionnidis J.P., Vlachoyiannopoulos P.G., Haidich A.B., et al. Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med 118 (2005) 2-10
24. Steen V., and Medsger T.A. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 43 (2000) 2437-2444
25. Steen V., Conte C., Owens G.R., and Medsger T.A. Severe restrictive lung disease in systemic sclerosis. Arthritis Rheum 37 (1994) 1283-1289
26. Feinstein A.R., Sosin D.M., and Wells C.K. The will Rogers phenomenon. N Engl J Med 312 (1985) 1604-1608
27. Erasmus L.D. Scleroderma in goldminers on the Witwatersrand with particular reference to pulmonary manifestations. S Afr Lab Clin Med 3 (1957) 209-231
28. Bonvenzi M., Barbone F., Pisa F.E., Betta A., and Romeo L. Scleroderma and occupational exposure to hand-transmitted vibration. Int Arch Occup Environ Health 74 (2001) 579-582
29. Valentini G., Della Rosa A., Bombardieri S., et al. European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis 60 (2001) 592-598